Biocardia Stock Return On Equity
BioCardia fundamentals help investors to digest information that contributes to BioCardia's financial success or failures. It also enables traders to predict the movement of BioCardia Stock. The fundamental analysis module provides a way to measure BioCardia's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioCardia stock.
BioCardia |
BioCardia Company Return On Equity Analysis
BioCardia's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current BioCardia Return On Equity | -7.04 |
Most of BioCardia's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioCardia is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, BioCardia has a Return On Equity of -7.0362. This is much lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
BioCardia Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioCardia's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioCardia could also be used in its relative valuation, which is a method of valuing BioCardia by comparing valuation metrics of similar companies.BioCardia is currently under evaluation in return on equity category among its peers.
BioCardia Fundamentals
Return On Equity | -7.04 | |||
Return On Asset | -1.33 | |||
Operating Margin | (41.36) % | |||
Number Of Shares Shorted | 4.26 K | |||
Revenue | 477 K | |||
EBITDA | (11.23 M) | |||
Net Income | (11.57 M) | |||
Total Debt | 1.31 M | |||
Book Value Per Share | (1.27) X | |||
Cash Flow From Operations | (9.97 M) | |||
Earnings Per Share | (3.20) X | |||
Number Of Employees | 16 | |||
Beta | 1.37 | |||
Total Asset | 2.99 M | |||
Retained Earnings | (152.18 M) | |||
Working Capital | (2.15 M) | |||
Net Asset | 2.99 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in BioCardia Stock
If you are still planning to invest in BioCardia check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioCardia's history and understand the potential risks before investing.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |